Finance

Lists
Why is BHVN down 4,42%?
Dive Deeper
BHVN:NYSE
Biohaven Ltd
10,93 US$
-4,42%
(-0,51) 1D
10,84 US$
-0,82% (-0,090)
After hours
Closed: 14 ოქტ, 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BHVN...
Open
11,39 US$
High
11,50 US$
Low
10,82 US$
Mkt. cap
1,65 მლრდ.
Avg. vol.
2,74 მლნ.
Volume
1,78 მლნ.
52-wk high
18,57 US$
52-wk low
7,48 US$
EPS
-4,64 US$
Beta
3,19
Shares outstanding
151,04 მლნ.
No. of employees
274
Open
11,39 US$
High
11,50 US$
Low
10,82 US$
Mkt. cap
1,65 მლრდ.
Avg. vol.
2,74 მლნ.
Volume
1,78 მლნ.
52-wk high
18,57 US$
52-wk low
7,48 US$
EPS
-4,64 US$
Beta
3,19
Shares outstanding
151,04 მლნ.
No. of employees
274
News stories
From web sources and news partners
About Biohaven Ltd
CEO-
Employees274
Founded2022
Headquartersნიუ-ჰეივენი, კონექტიკუტი, ამერიკის შეერთებული შტატები
Sector-
Analyst ratings
Based on 11 analysts giving stock ratings to BHVN in the past 3 months
Buy
Buy
7
Hold
3
Sell
1
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for BHVN in the last 3 months.
Highest
Current 10,93 US$
30,00 US$ (+174,47%)
Average
19,63 US$ (+79,60%)
Lowest
10,00 US$ (-8,51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dina Ramadane
Bank of America Securities
Sell
Maintained
11,00 US$
+0,6%
10/12/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
21,00 US$
+92,1%
10/09/2026
Samantha Semenkow
Citi
Buy
Maintained
17,00 US$
+55,5%
09/17/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
-
-
09/13/2026
Douglas Tsao
H.C. Wainwright
Hold
Maintained
10,00 US$
-8,5%
09/10/2026
Christopher Raymond
Raymond James
Buy
Maintained
-
-
09/10/2026
Myles Minter
William Blair
Hold
Reiterated
-
-
09/09/2026
Leonid Timashev
RBC Capital
Hold
Downgraded
19,00 US$
+73,8%
09/08/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
30,00 US$
+174,5%
08/17/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
19,00 US$
+73,8%
08/12/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
30,00 US$
+174,5%
08/11/2026
David Hoang
Deutsche Bank
Buy
Reiterated
20,00 US$
+83%
06/26/2026
Corinne Johnson
Goldman Sachs
Buy
Maintained
25,00 US$
+128,7%
05/28/2026
Ashwani Verma
UBS
Hold
Reiterated
11,00 US$
+0,6%
05/28/2026
Unknown Analyst
Bernstein
Hold
Maintained
9,00 US$
-17,7%
05/13/2026
Last report
10 აგვ. 2026
Fiscal period
Q2 2026
-0,78 US$ / -0,61 US$
-27,61%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
141,17 მლნ.
84,93 მლნ.
103,83 მლნ.
100,81 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28,21 მლნ.
20,79 მლნ.
26,60 მლნ.
24,08 მლნ.
Operating expense
169,38 მლნ.
105,72 მლნ.
130,43 მლნ.
124,90 მლნ.
Total operating expenses
169,38 მლნ.
105,72 მლნ.
130,43 მლნ.
124,90 მლნ.
Operating income
-169,38 მლნ.
-105,72 მლნ.
-130,43 მლნ.
-124,90 მლნ.
Other non operating income
-7,25 მლნ.
-5,29 მლნ.
-3,08 მლნ.
-14,70 მლნ.
EBT including unusual items
-173,22 მლნ.
-145,20 მლნ.
-130,26 მლნ.
-136,92 მლნ.
EBT excluding unusual items
-176,63 მლნ.
-111,01 მლნ.
-133,51 მლნ.
-139,60 მლნ.
Income tax expense
221,00 ათ.
351,00 ათ.
272,00 ათ.
391,00 ათ.
Effective tax rate
-0,13%
-0,24%
-0,21%
-0,29%
Other operating expenses
-
-
-
-
Net income
-173,44 მლნ.
-145,56 მლნ.
-130,53 მლნ.
-137,31 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-1,47
-0,90
-0,69
-0,78
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-166,26 მლნ.
-103,15 მლნ.
-128,06 მლნ.
-122,64 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები